Lionex GmbH - Company Review
Lionex GmbH - Company ReviewSummary
Lionex GmbH (Lionex) is a biotechnology company that operates in the fields of biomedicine and human health with emphasis on tuberculosis. The company’s product line comprise recombinant proteins, antigens, immunotherapeutic, vaccines and invitro diagnostic kits, among others. It offers services such as custom production of recombinant proteins and plasmid DNA to institutions and industries for research. Lionex focus on research and product development of infectious diseases and cancer. The company develops novel Diagnostics for Tuberculosis and HIV based on a series of proprietary platforms. It expertise in the areas of custom production of recombinant proteins in systems including E.coli, Insect cells, B.subtilis, Lactococcus lactis, M.smegmatis. Lionex is headquartered in Braunschweig, Germany.
This comprehensive company report of Lionex GmbH provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.